vanilmandelic acid has been researched along with Brain Disorders in 2 studies
Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stoica, T | 1 |
| Coculescu, M | 1 |
| Chivu, V | 1 |
| Iosif, G | 1 |
| Wender, PH | 1 |
| Epstein, RS | 1 |
| Kopin, IJ | 1 |
| Gordon, EK | 1 |
2 other studies available for vanilmandelic acid and Brain Disorders
| Article | Year |
|---|---|
[Functional adrenergic attacks with paroxysmal arterial hypertension].
Topics: Adolescent; Adult; Brain Diseases; Catecholamines; Diencephalon; Dysautonomia, Familial; Epilepsy; E | 1970 |
Urinary monoamine metabolites in children with minimal brain dysfunction.
Topics: Adolescent; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Brain Damage, Chro | 1971 |